We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.74 | 1.49% | 50.31 | 50.23 | 50.28 | 50,822 | 13:31:32 |
From May 2019 to May 2024
By Marc Navarro Gonzalez
Sanofi SA (SAN.FR) said Thursday that it is investing 350 million euros ($432.9 million) for the construction of a vaccine manufacturing facility in Canada.
The investment will increase its capacity to meet growing demand for pediatric and booster vaccines, the company said.
The facility will produce the antigens used in the diphtheria and tetanus vaccines, it said.
The building will be located at the Sanofi Pasteur Canadian headquarters in Toronto and construction will be completed in 2021, the company said.
Write to Marc Navarro Gonzalez at marc.navarro@dowjones.com
(END) Dow Jones Newswires
April 12, 2018 01:29 ET (05:29 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
